The recent lockdown in Shanghai, China, has had a serious impact on GE Healthcare's primary pharmaceutical manufacturing facility for iohexol (Omipaque, GE Healthcare) iodinated contrast media (ICM), ...
In a new practice advisory, an international team of experts discussed the use of gadolinium-based contrast agents (GBCAs), an alternative to iodinated contrast media, in interventional pain ...
Iodixanol Injection, USP is bioequivalent and therapeutically equivalent to Visipaque ®, rendering it fully substitutable to the brand, and is the first generic iodinated contrast media agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback